LSE

Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102

Retrieved on: 
Tuesday, November 7, 2023
United Kingdom, Biotechnology, Sorriso, Ulcerative colitis, Pharmacokinetics, PK, IBD, LSE, Safety, Patient, Pharmaceutical industry

LONDON, 1 November 2023: Arix Bioscience plc (“Arix” or the “Company”) (LSE: ARIX), a transatlantic venture capital company focused on investing in breakthrough biotechnology companies, notes that its Core Portfolio company, Sorriso Pharmaceuticals (“Sorriso”), has announced that the first subject has been dosed in the Company’s Phase 1/1b clinical program of SOR102.

Key Points: 
  • LONDON, 1 November 2023: Arix Bioscience plc (“Arix” or the “Company”) (LSE: ARIX), a transatlantic venture capital company focused on investing in breakthrough biotechnology companies, notes that its Core Portfolio company, Sorriso Pharmaceuticals (“Sorriso”), has announced that the first subject has been dosed in the Company’s Phase 1/1b clinical program of SOR102.
  • This Phase 1 trial is a randomized, double-blind study consisting of three parts.
  • Part 3 will evaluate safety, tolerability, PK, and clinical and biological activity of multiple oral doses of SOR102 in patients with mild to severe ulcerative colitis.
  • The trial is expected to enrol up to 60 adult participants at sites in the United Kingdom and Europe.

Custodian Property Income REIT plc: Notice of General Meeting

Retrieved on: 
Tuesday, November 7, 2023
AGM, Mass meeting, REIT, Notice, LSE, Property income, Security (finance)

Custodian Property Income REIT plc: Notice of General Meeting

Key Points: 
  • Custodian Property Income REIT plc: Notice of General Meeting
    Custodian Property Income REIT (LSE: CREI), which seeks to deliver an enhanced income return by investing in a diversified portfolio of smaller, regional properties with strong income characteristics across the UK, today announces that a general meeting of the Company will be held at 6th floor, Saddlers House, 44 Gutter Lane, London EC2V 6BR, United Kingdom on 21 November 2023 at 9:30am.
  • The Board has become aware that a scheduled continuation vote required by the Company’s Articles of Association at every seventh annual general meeting (“AGM”) of the Company was not proposed at the AGM held on 1 September 2020.
  • As a result, the Company will seek the approval of Shareholders to ratify this oversight.
  • The Notice of General Meeting (“Notice”) has been distributed to shareholders and is available to view at:
    A copy of the Notice will shortly be available for inspection on the National Storage Mechanism.

One Heritage Group plc: Full year results for the year ending 30 June 2023

Retrieved on: 
Tuesday, November 7, 2023
Sale, Real estate development, Acquisition, Risk, Heritage, Victoria Road, Accounting, LSE, Parent, Lincoln House, Liberty House, Howard County Housing and Community Development, Northern England, Construction, Pharmaceutical industry, Property management, Tunnel, Churchgate, Eccleshill

One Heritage Group PLC (LSE: OHG), the UK-based residential developer, development manager and property manager focused on the North of England, is pleased to announce its audited results for the year ended 30 June 2023 (FY 2023).

Key Points: 
  • One Heritage Group PLC (LSE: OHG), the UK-based residential developer, development manager and property manager focused on the North of England, is pleased to announce its audited results for the year ended 30 June 2023 (FY 2023).
  • Increase in revenue of £13.84m, +792% on the prior year, from £1.75m to £15.59m, driven by 71 sale completions during the period.
  • Impairment was £1.09m in the period, a decrease of £0.01m on the impairment reported in the interim announcement.
  • In May 2023, the Group received its Arla Propertymark accreditation, a nationally recognised code of practice, for its Lettings operation.

MaxCyte to Participate in Two Upcoming Investor Conferences

Retrieved on: 
Monday, November 6, 2023
LSE, Therapy, Mobile phone, Pharmaceutical industry

ROCKVILLE, Md., Nov. 06, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and innovative bioprocessing applications, today announced Company management will participate at two upcoming investor conferences.

Key Points: 
  • ROCKVILLE, Md., Nov. 06, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and innovative bioprocessing applications, today announced Company management will participate at two upcoming investor conferences.

Canadian General Investments: Investment Update - Unaudited

Retrieved on: 
Friday, November 3, 2023
LSE, NAV, S&P/TSX, TSX, Generation Investment Management, CGI

TORONTO, Canada, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Canadian General Investments, Limited (CGI) (TSX:CGI) (LSE: CGI) reports on an unaudited basis that its net asset value per share (NAV) at October 31, 2023 was $50.60, resulting in year-to-date and 12-month NAV returns, with dividends reinvested, of 6.3% for both periods.

Key Points: 
  • TORONTO, Canada, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Canadian General Investments, Limited (CGI) (TSX:CGI) (LSE: CGI) reports on an unaudited basis that its net asset value per share (NAV) at October 31, 2023 was $50.60, resulting in year-to-date and 12-month NAV returns, with dividends reinvested, of 6.3% for both periods.
  • These compare with the 0.1% and 0.4% returns of the benchmark S&P/TSX Composite Index on a total return basis for the same periods.
  • The Company employs a leveraging strategy, by way of bank borrowing, with the intent to enhance returns to common shareholders.
  • The sector weightings of CGI’s investment portfolio at market as of October 31, 2023 were as follows:

Gran Tierra Energy Inc. Announces Normal Course Issuer Bid and Automatic Share Purchase Plan

Retrieved on: 
Tuesday, October 31, 2023
Gran Tierra Energy, CDN, NYSE, GTE, Toronto Stock Exchange, LSE, NYSE American, Calendar, TSX, BID, Security (finance), Auction, Share (finance)

CALGARY, Alberta, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Gran Tierra Energy Inc. (“Gran Tierra”) (NYSE American: GTE)(TSX: GTE)(LSE: GTE), today announces that the Toronto Stock Exchange (“TSX”) has approved its notice of intention to make a normal course issuer bid (the “Bid”) for its shares of common stock (the “Shares”).

Key Points: 
  • CALGARY, Alberta, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Gran Tierra Energy Inc. (“Gran Tierra”) (NYSE American: GTE)(TSX: GTE)(LSE: GTE), today announces that the Toronto Stock Exchange (“TSX”) has approved its notice of intention to make a normal course issuer bid (the “Bid”) for its shares of common stock (the “Shares”).
  • Gran Tierra has also entered into an Automatic Share Purchase Plan (the “ASPP”) in connection with the Bid.
  • The brokerage firm conducting the Bid on behalf of Gran Tierra and administering the ASPP is Eight Capital.
  • The ASPP is intended to allow for the purchase of Shares under the Bid when Gran Tierra would ordinarily not be permitted to purchase Shares due to regulatory restrictions and customary self-imposed blackout periods.

Gran Tierra Energy Inc. Announces Third Quarter 2023 Results Including the Highest Production Since the Second Quarter of 2019, Net Income of $7 Million and $36 Million of Free Cash Flow

Retrieved on: 
Tuesday, October 31, 2023
Gran Tierra Energy, Line of credit, Return on capital employed, NYSE, GTE, Total average, Prior, EBITDA, G&A, Transport, Quarter, Maintenance, TSX, Senior, Growth, Capital expenditure, BOPD, LSE, Lifting, Administration, Second, Video game, Security (finance), Oil, Tutoring, Life insurance, Duchy of Gascony, Operation

For per bbl amounts based on net after royalty (“NAR”) production, see Gran Tierra’s Quarterly Report on Form 10-Q filed October 31, 2023.

Key Points: 
  • For per bbl amounts based on net after royalty (“NAR”) production, see Gran Tierra’s Quarterly Report on Form 10-Q filed October 31, 2023.
  • Gran Tierra’s production in the Quarter was the Company’s highest quarterly average total production since second quarter 2019.
  • Net Income: Gran Tierra achieved net income of $7 million, compared to a net loss of $11 million in the Prior Quarter and net income of $39 million one year ago.
  • Free Cash Flow(2): During the Quarter, the Company generated free cash flow of approximately $36 million.

Gran Tierra Energy Inc. Announces Appointment of Chief Operating Officer

Retrieved on: 
Tuesday, October 31, 2023
Workover, NYSE, GTE, Exploration, Gulf of Mexico, Geology, University, Imperial Oil, Geological engineering, LSE, TSX, Esso, ExxonMobil, Management, Gran Tierra Energy, Operation

CALGARY, Alberta, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Gran Tierra Energy Inc. ("Gran Tierra" or the "Company") (NYSE American:GTE)(TSX:GTE)(LSE:GTE) is pleased to announce the appointment of Mr. Sebastien Morin as Chief Operating Officer (“COO”).

Key Points: 
  • CALGARY, Alberta, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Gran Tierra Energy Inc. ("Gran Tierra" or the "Company") (NYSE American:GTE)(TSX:GTE)(LSE:GTE) is pleased to announce the appointment of Mr. Sebastien Morin as Chief Operating Officer (“COO”).
  • Mr. Morin will be joining Gran Tierra as COO, located in Calgary and will report to Gary Guidry, President and Chief Executive Officer.
  • Gary Guidry, President and Chief Executive Officer of Gran Tierra, commented: "We are very pleased to welcome Sebastien back to Gran Tierra in the new position of COO.
  • Sebastien was integral in Gran Tierra becoming best in class in its drilling, operations, and execution of capital programs.

Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics

Retrieved on: 
Monday, October 30, 2023
MSA, NMPA, TP53, Hope, Boehringer Ingelheim, National Medical Products Administration, Master service agreement, Research, Rock, Partnership, Cancer, LSE, BTC, Safety, Patient, Pharmaceutical industry, Water Drops on Burning Rocks

GUANGZHOU, China, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”) is pleased to announce that the Company and Boehringer Ingelheim officially have signed the Master Service Agreement (MSA) in the field of oncology companion diagnostics.

Key Points: 
  • GUANGZHOU, China, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”) is pleased to announce that the Company and Boehringer Ingelheim officially have signed the Master Service Agreement (MSA) in the field of oncology companion diagnostics.
  • This partnership will primarily focus on advancing the clinical trials related to Boehringer Ingelheim's MDM2-p53 antagonist, brigimadlin (BI 907828), and the development of companion diagnostic products in China.
  • Mr. Yusheng Han, Founder and CEO of Burning Rock, expressed, “We are delighted to establish a deep collaboration in companion diagnostics with Boehringer Ingelheim.
  • Burning Rock has a comprehensive layout and supports companion diagnostics development with a global perspective for pharmaceutical companies.

Funding Circle U.S. Appoints Kos Joshi to Lead Embedded Finance & Partnerships

Retrieved on: 
Monday, November 6, 2023
Technology, Finance, Fintech, Banking, Professional Services, Small Business, Software, Internet, Other Professional Services, LSE, FCH, SMB, Goldman Sachs, Amazon, Small business, Partnership, SBA, Funding Circle, Multimedia, Bank

Funding Circle (LSE:FCH), the leading online lending platform for small businesses is pleased to announce that Kaustubh “Kos” Joshi has joined the company as the Head of Embedded Finance & Partnerships for the U.S. business where he will be responsible for executing on the company’s strategy to attract more small businesses through its embedded platform and strategic partnerships.

Key Points: 
  • Funding Circle (LSE:FCH), the leading online lending platform for small businesses is pleased to announce that Kaustubh “Kos” Joshi has joined the company as the Head of Embedded Finance & Partnerships for the U.S. business where he will be responsible for executing on the company’s strategy to attract more small businesses through its embedded platform and strategic partnerships.
  • View the full release here: https://www.businesswire.com/news/home/20231106885931/en/
    Kaustubh “Kos” Joshi has been appointed to Head of Embedded Finance & Partnerships at Funding Circle U.S. (Photo: Business Wire)
    Kos was most recently the Head of Product for Embedded Business Financing at Goldman Sachs where he successfully launched and grew their embedded SMB financing business, including their partnership with Amazon .
  • "I am thrilled to lead Funding Circle’s strategy to attract more small businesses through our flexible embedded platform which leverages world class technology and superior customer experience to offer small businesses multiple financing products including SBA 7(a) loans that meet their needs wherever they are,” Kos said.
  • Partners such as banks, lenders and other service providers to small businesses will be able to offer their customers Funding Circle term loans and SBA 7(a) loans up to $500,000 through Funding Circle’s flexible embedded platform .